News

April 2010

Sentinel Oncology awarded grant to further cancer research

Sentinel Oncology are pleased to announce that they have recently been awarded a development grant from the East of England… read more

March 2010

FLT3 programme licensing opportunity

Sentinel Oncology is pleased to announce that its FLT3 kinase programme is available for partnering. Mutations in the… read more

Welcome to Sentinel Oncology

Sentinel Oncology is a privately owned drug discovery company developing novel drugs for the treatment of cancer.  Our business model is to advance innovative ideas from concept to pre-clinical candidate drug selection.  We license our products at the pre-clinical development stage and have exclusive collaborations already in progress. More.....